Real Academia Nacional de Farmacia RANF
@ranfarmacia • Joined November 17, 2016
At a glance
Subscribers
Last 27 days402
Views
Last 27 days39.2K
Videos
Last 27 days312
Charts
Subscribers, views & videos over time
Subscribers gained (weekly) · 6 mo
Views gained (weekly) · 6 mo
Subs milestone changes (up to 30)
Views milestone changes (up to 30)
Engagement
Avg. views per video
126
Total views ÷ total videos
Views per subscriber
98×
Total views ÷ subscribers
Subs per video
1
Subscribers ÷ total videos
Revenue estimate
Details →Total (all-time): $27 – $79
Daily avg.: $0 – $0
Weekly avg.: $0 – $0
Last 27 days: $0 – $1
Based on estimated $0.7–$2 CPM.
Analytics tables
Analytics Table:Real Academia Nacional de Farmacia RANF
| Date | subscribers | views | videos |
|---|---|---|---|
Jun 29, 2026 Jun 29 Mon | 402 -- | 39.2K +6 | 312 -- |
Jun 22, 2026 Jun 22 Mon | 402 -- | 39.2K +85 | 312 -- |
Jun 15, 2026 Jun 15 Mon | 402 +2 | 39.1K +114 | 312 -- |
Jun 14, 2026 Jun 14 Sun | 400 -- | 39.0K +165 | 312 +1 |
Jun 3, 2026 Jun 3 Wed | 400 +7 | 38.9K +656 | 311 +4 |
May 14, 2026 May 14 Thu | 393 -- | 38.2K -- | 307 -- |
Subscribers gained (weekly)
| Week | Subscribers gained | Change vs prev |
|---|---|---|
Jun 3, 2026 | 7 | +7 |
Jun 14, 2026 | 0 | -7 |
Jun 15, 2026 | 2 | +2 |
Jun 22, 2026 | 0 | -2 |
Jun 29, 2026 | 0 | -- |
Views gained (weekly)
| Week | Views gained | Change vs prev |
|---|---|---|
Jun 3, 2026 | 656 | +656 |
Jun 14, 2026 | 165 | -491 |
Jun 15, 2026 | 114 | -51 |
Jun 22, 2026 | 85 | -29 |
Jun 29, 2026 | 6 | -79 |
About
Fomentar la investigación y el estudio de las Ciencias Farmacéuticas y sus afines. Asesorar al Gobierno de la Nación, Administraciones públicas, Organismos públicos, Agencia Española del Medicamento, Agencias Científicas y tecnológicas y a cuantas instituciones públicas o privadas lo soliciten, en todo lo que se refier…
- Handle
- @ranfarmacia
- Joined
- November 17, 2016
More features coming
We're working on new analytics and tools. Stay tuned.
More features coming
We're working on new analytics and tools. Stay tuned.